Singular Genomics Launches G4X (TM) in the U.S., Delivering Industry-Leading Throughput for In Situ Multiomics, Targets Translational and Clinical Applications ...

Genomics’ fourth quarter results saw stable revenue performance despite a subdued research funding environment, with ...

The growth of the genomics market is driven by the rising prevalence of genetic disorders and cancer, along with increasing awareness of early disease detection through genetic testing. WILMINGTON, ...

Segun Fatumo discusses how he is working towards a true global genomics framework and strengthening African research capacity ...

PLEASANTON, Calif., Feb. 19, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial ...

Every living organism has its own genetic "blueprint": the source code for how it grows, functions and reproduces. This ...

Biotech company 10x Genomics (NASDAQ:TXG) reported in Q4 CY2025, but sales were flat year on year at $166 million. The ...

When people think of genomics, they typically don’t visualize the primary care setting — but Northshore–Edward Elmhurst Health is trying to change that. Genomics is a key part of the health system’s ...

The longevity market is shifting from wellness to institutional healthcare, driven by AI, genomics, and regenerative medicine. Opportunities lie in integrated platforms for early risk detection and ...

Future AI-guided genomic analysis offers the potential to further optimize gene constructs, expression profiles, and performance traits, accelerating the development of next-generation materials.

Dr. Shaun P. McKenzie is board certified in general surgery and in surgical oncology, hepatobiliary surgery, and pancreatic surgery. He is a surgical oncologist with Texas Oncology Surgical ...

Basepair, a leader in cloud-native bioinformatics analysis, and Sciencewerke Pty Ltd, an Australian specialist in research ...